ESSO Course on Peritoneal Surface Malignancy



Similar documents
2 nd ESSO Advanced Course on the Surgical and Medical Management of Melanoma

Enhanced Recovery after Surgery: Benefits, Challenges and Solutions for Implementation

Highly Specialised Services. Peritoneal Oncology Service. Report September 2015

ESSO Advanced Course on Oncoplastic Breast Surgery June 2016

Luis D. Carcorze Soto, MD PGY-3

Peritoneal Surface Malignancies. Ira Allen Jacobs, MD, FACS Surgical Oncology San Diego, CA

Intraoperative Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Volodymyr Labinskyy MD

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Now and the Future

2nd International Symposium on Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)

Chirurgia Avanzata Del Carcinoma Ovarico Nuove Strategie A Confronto Ovarian Cancer Advanced Surgery New Strategies in Comparison

ONCOLOGY NURSING 7 TH ESO-EONS MASTERCLASS IN March 2014 Ermatingen (Lake Constance) Switzerland MASTERCLASS

Pseudomyxoma Peritonei Where are we in 2014?

Cytoreduction and hyperthermic intraperitoneal chemotherapy for the treatment of pseudomyxoma

15th Colorectal Day Programme

GOLNIK 17/06/10 COURSE ON LUNG CANCER AND MESOTHELIOMA June 2010 Golnik, Slovenia. Chair: T. Cufer, SI - G.L. Ceresoli, IT

Advances in Surgical Oncology

How To Teach A Patient To Live With A Tumour

Quick Facts about Appendix Cancer

International Symposium on Malignant Pleural Mesothelioma

Rachel E. Kirby, Jing Zhao, Terence Chua, Winston Liauw and David L. Morris *

INTRAOPERATIVE HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY (HIPEC)

1 page Overview. CONCURRENT 1D, 1E, 1F Biology & Pathogenesis Multi-Modality Immunology 1

ELCC 2015 Industry Satellite Symposium The Treatment Roadmap for Squamous NSCLC. Thursday 16th April :10 14:20 Room C

Villejuif, Paris, France

Corporate Medical Policy

Cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis in the elderly

CLINICAL ONCOLOGY MASTERCLASS IN April 2015 São Paulo, Brazil. Chairs: Scientific Co-ordinators: ESO - LATIN-AMERICAN PROGRAMME

National Bowel Cancer Audit Report 2008 Public and Executive Summary

Clinical Commissioning Policy: Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Mesothelioma

Die multimodale Behandlung der Peritonealkarzinose

Population Pharmacokinetics and Pharmacodynamics of Cisplatinum During Intraperitoneal Chemohyperthermia Using a Closed Abdominal Procedure

CANCERS OF THE PERITONEUM PERITONEAL MESOTHELIOMA PREFERRED MODEL OF CARE AND CRITERIA FOR REFERENCE CENTRES

SUMMER SCHOOL organised by the Hepatology Committee of ESPGHAN

BOWEL CANCER. The doctor has explained that you have a growth or tumour, in your bowel or rectum and could be cancer.

SKIN MELANOMA September 2006, Istanbul, TR

Scientific Committee Hilary Calvert UCL Cancer Institute, London, United Kingdom

REPORT ON STOMA SERVICE AND PRACTICE. MM / YY to MM / YY. Name: Title: Centre:

H. Richard Alexander, Jr., M.D. Department of Surgery and The Greenebaum Cancer Center University of Maryland School of Medicine Baltimore, Md

National Medical Policy

POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS DISCLAIMER CODING INFORMATION REFERENCES POLICY HISTORY

Columbia University Mesothelioma Applied Research Foundation Mesothelioma Center

COMMISSIONING. for ULTRA-RADICAL SURGERY ADVANCED OVARIAN CANCER

How To Manage A Cancer Oncology Clinic

How To Treat Mesothelioma

GRANT APPLICATION FORM: ORGANISING AN ESO EDUCATIONAL EVENT

IN MANY PATIENTS WITH ABDOMINAL OR PELVIC MALIGNANCIES, surgical treatment

Information for Men Diagnosed with Testicular Cancer

Peritoneal Carcinosis

Fact sheet 10. Borderline ovarian tumours. The difficult cases. What is borderline ovarian cancer (BOC)?

Program Chairs: Robert W. Holloway, MD and Martin Martino, MD Speakers and times are subject to change

Scientific Programme

Gentofte Workshop 2013

FRIDAY MAY 9, Seattle, WA

EMRI ERASMUS COURSE ON MAGNETIC RESONANCE. MRI Abdominal Module

INTRAPERITONEAL HYPERTHERMIC CHEMOTHERAPY (IPHC) FOR PERITONEAL CARCINOMATOSIS AND MALIGNANT ASCITES. INFORMATION FOR PATIENTS AND FAMILY MEMBERS

Treating Mesothelioma - A Quick Guide

J Clin Oncol 27: by American Society of Clinical Oncology INTRODUCTION

OVARIAN CANCER TREATMENT

Richmond meets Salzburg

Gentofte Workshop. Gentofte. Hospital 10/2012. University. Training Centre

Mapping quality assurance approaches in Europe

Clinical Policy Bulletin: Hyperthermia in Cancer Therapy

E UROPEAN PERSONAL INFORMATION

Healthcare Management

How do I find the best place to get treatment for my lymphoma?

Salisbury Lung Cancer Service (1 of 5)

Gynaecological Cancers 2015

British Thoracic Oncology Group (BTOG) Annual Report - April 2014 to March 2015

PRODYNOV. Targeted Photodynamic Therapy of Ovarian Peritoneal Carcinomatosis ONCO-THAI. Image Assisted Laser Therapy for Oncology

How To Prepare A Meeting For A Health Care Conference

ORGANIZERS Fundación para la Investigación Médica Aplicada FIMA Clínica Universidad de Navarra CUN

A succesfull case of HIPEC in a peritoneal mesothelioma patient

Cytoreduction and Intraperitoneal Chemotherapy for the Management of Non-Gynecological Peritoneal Surface

Professional Managers Annual Conference Adding value to business schools Programme

Please see the LUCADA data manual v3.1.3, available in the downloads section

FAMILIAL CANCER ESO, CNIO AND NRCO CONFERENCE ON May 2016 Madrid, Spain. Chairs: R. Eeles, UK W.D. Foulkes, CA M. Robledo, ES H.

Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Peritoneal Mesothelioma

Understanding CA 125 Levels A GUIDE FOR OVARIAN CANCER PATIENTS. foundationforwomenscancer.org

Guideline for the Follow Up of Patients Following Treatment for Breast Cancer

Bristol Hospital Cancer Care Center 2015 Annual Report

Minimally Invasive Cardiac Surgery

ONDON. Complications in Spine Surgery An International Educational Training Program. Course Chairmen: 5-6 June, 2015 London, UK

PREPARING FOR YOUR STOMA REVERSAL

Transcription:

ESSO Course on Peritoneal Surface Malignancy In partnership with The Christie School of Oncology 08-09 October 2015 MANCHESTER (UK)

ESSO Course on Peritoneal Surface Malignancy Chair: Sarah O Dwyer, The Christie NHS Foundation Trust, Manchester, UK Co-Chair: Santiago González-Moreno, MD Anderson Cancer Center, Madrid, SP Faculty Members Thomas Bacheitner- Hofmann, Medical University of Vienna, AT Norman Carr, Basingstoke and North Hampshire Hospital, Basingstoke, UK Tom Cecil, Basingstoke and North Hampshire Hospital, Basingstoke, UK Marcello Deraco, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, IT Charles Honoré, Institut de Cancérologie Gustave Roussy, Villejuif, FR Brendan Moran, Basingstoke and North Hampshire Hospital, Basingstoke, UK Pompiliu Piso, St. John of God Hospital, Regensburg, DE Beate Rau,Charité Campus Mitte, Berlin, DE Josefin Segelman, Karolinska Institut, Solna, Stockholm, SE Paul H Sugarbaker, Washington Cancer Center, Washington, USA Kurt Van der Speeten, Ziekenhuis Oost-Limburg, Genk, BE Vic Verwaal, The Netherlands Cancer Institute, Amsterdam, NL Willemien van Driel, Netherlands Cancer Institute, Amsterdam, NL Local Faculty Omar Aziz Rahul Deshpande Paul Fulford Vidya Kasipandian Rohit Kochhar Andrew Renehan Mark Saunders Chelliah Selvasekar Malcolm Wilson

Aim of the course A comprehensive workshop on Peritoneal Surface Malignancies addressing current treatments for specific tumour groups and future challenges for developing services in different health care settings. The course will focus on delivering evidence-based clinical practice and achieving quality assured outcomes for patients undergoing abdominal and pelvic cytoreductive surgery and intraperitoneal chemotherapy. Topics covered Neoplasia of the appendix: pathology, diagnosis and clinical pathways Peritoneal Surface Malignancies: outcomes for colorectal, ovarian, gastric cancers and mesothelioma Surgical techniques: tips and tricks to achieve complete cytoreduction Intraperitoneal chemotherapy: why, what, who and how Setting up a service: challenges and opportunities Ideal Course candidates Consultant Surgeons/gynaecologists/oncologists Senior residents/fellows surgery/gynaecology/oncology Senior Nurse Practitioners in PSM/oncology Educational methods Live surgical session with interactive discussion Video sessions/workshops on surgical technique and HIPEC Plenary lectures MDT case management Interactive voting on key topics Course Venue The Christie NHS Foundation Trust Wilmslow Road Manchester, M20 4BX United Kingdom

Course coordination Ana Galán European Society of Surgical Oncology (ESSO) Email. ana.galan@essoweb.org Application Procedure Please go to www.essoweb.org (education/projects & courses) to complete your application and apply for the course. Participation fee The participation fee is 650 for ESSO members and 800 for non-members. It includes registration for the 2-day course,coffee breaks and lunches and a social dinner. Accreditation An application for accreditation has been submitted to the European Accreditation Council for CME (EACCME) of the European Union of Medical Specialists (UEMS).

Programme Thursday 08 October Welcome 08:15-08:30 Aims and objectives; global guidelines S. O Dwyer, S.González-Moreno Generic challenges in PSM Service delivery for PSM Moderators: B. Moran, P. Piso 08:30-08:45 The European picture: reference centres and networks S.González-Moreno 08:45-09:00 Setting up a service: challenges and opportunities T. Bacheitner - Hofman 09:00-09:05 Discussion 09:05-09:35 Imaging for PSM: what the MDT should look for R. Kochar 09:35-09:40 Discussion 09:40-10:10 Keynote address: Evidence base and principles of management of peritoneal metastases P. Sugarbaker Chemotherapy Moderators: A. Renehan, V. Verwaal 10:10-10:25 HIPEC: overview of current regimes K. Van der Speeten 10:25-10:30 Can we reach a consensus: voting 10:30-10:40 Systemic chemotherapy: when how and what M. Saunders 10:40-10:50 EPIC: when how and what K. Van der Speeten 10:50-10:55 Can we reach a consensus: voting 10:55-11:15 Coffee break Perioperative support: tips and tricks Moderators: P. Fulford, T.B- Hofmann 11:15-11:30 Anaesthesia, critical care and pain management V. Kasipandian 11:30-11:45 Nutrition and enhanced recovery O. Aziz 11:45-12:00 Complications: how to avoid them B. Rau 12:00-12:15 Standardised recording of morbidity and mortality A. Reneham

12:15-12:30 Recommendations for follow up: why, who and for how long? T. Cecil 12:30-12:45 Discussion/voting 12.45-13.30 Lunch Surgical techniques: tips and tricks Moderators: M. Wilson, S.G. Moreno 13:30-14:30 RUQ, R. Deshpande LUQ, P. Piso Central abdomen, M. Deraco Pelvis, T. Cecil MAS, C. Selvaseker HIPEC, K. Van der Speeten 14:30-14:45 Discussion 14:45-15:00 Coffee break Parallel sessions 15:00-17:00 Surgical techniques workshops/videos MDT case discussions Pathology workshop Nursing workshop Friday 09 October Disease specific challenges in PSM Appendix neoplasia Moderators: P. Fulford, M. Deraco 08:30-08:55 Keynote address: Concensus on the classification of appendix neoplasia N. Carr 08:55-09:00 Discussion 09:00-09:15 PMP Presentation and outcomes M. Wilson 09:15-09:30 Management of recurrence B.Moran 09:30-09:40 Discussion Surgery Moderators: S. O Dwyer, C. Selvaseker, A. Renehan, P. Fulford 09:40-10:15 Case Presentation and Live Surgery 10.15-10.45 Coffee break

Colon and rectum Moderator: P. Piso 10:45-11:00 Patient selection and outcomes C. Honore 11:00-11:10 Selecting high risk patients J. Segelman 11:10-11:25 Future opportunities for CRS in colorectal cancer P.Sugarbaker 11:25-11:30 Discussion Surgery 11:30-12:00 Live surgery/ case discusion Mesothelioma Moderator: T. Cecil 12:00-12:40 Keynote address: Current and Future directions for the treatment of Peritoneal Mesothelioma M. Deraco 12:40-12:45 Discussion 12:45-13:45 Lunch (live surgery continues during lunch break) Gastric Cancer Moderator: C. Honore 13:45-14:10 Patient selection outcomes and future potential P. Piso 14:10-14:15 Discussion Surgery 14:15-14:30 Live surgery Ovarian Cancer Moderator: V. Verwaal 14:30-15:00 Keynote adress: Evidence base and recommendations for the treatment of ovarian peritoneal metastasis W. van Driel 15.00-15.05 Discussion Palliative treatment for PSM Moderator: B.Rau 15:05-15:20 Strategies and outcomes from palliation K. Van der Speeten 15:20-15:25 Discussion 15:25-15:50 MDT Case discussions/live surgery update 15:50-16:00 Summary and Close

ESSO is grateful for the continuous support of its corporate sponsors European Society of Surgical Oncology (ESSO) Avenue E. Mounier 83 B 1200 Brussels Tel: +32 (0)2 5373106 Fax : +32 (0) 5390374 Email : info@essoweb.org Website : www.essoweb.org